The BVA-100 (Blood Volume Analyzer) is a revolutionary instrument, developed by DAXOR Corporation and cleared by the FDA, to precisely measure blood volume in the human body.

Read More

Key Features

  • Superior  blood volume measurement
  • Results in under 1 hour
  • Clinically proven — used in leading hospitals

Latest News

Daxor Receives Two Patents, One for Measurement of Total Body Albumin and a Second Patent for Improved Accuracy of Blood Volume Measurement

Daxor has received approval from the US Patent Office for a Total Body Albumin Analyzer, US Patent # 9,002,656. The patent for the total body albumin analyzer is the first one issued for an instrument to measure the total albumin within the human body.  Albumin is the major carrier molecule in the human body for […]

Read More

Second Heart Failure Study from the Mayo Clinic Utilizing Daxor’s BVA-100 Blood Volume Analyzer Published in Journal of Cardiovascular Trans. Res. (2015) 8:404-410

(NYSE MKT: DXR) A study from the Mayo Clinic by Wayne L. Miller, MD, PhD. and Brian P. Mullan, MD, involved 32 patients admitted for congestive heart failure with a diagnosis of volume overload. The focus of the study was whether peripheral hemoglobin measurements which measure the red blood cell concentration accurately reflect the total red blood […]

Read More

Heart Failure Research from the Mayo Clinic Utilizing the BVA-100 Blood Volume Analyzer presented at the Annual Heart Failure Society of America Meeting

Daxor Corporation, (NYSE MKT: DXR), a medical instrumentation and biotechnology company, announced that Dr. Wayne Miller, a cardiologist from the Mayo Clinic, presented research at the annual meeting of the Heart Failure Society which documented and quantified blood volume derangements in congestive heart failure patients. The study demonstrated that the majority of congestive heart failure […]

Read More